Literature DB >> 25243044

Physical functioning for prostate health.

Roanne Segal1.   

Abstract

Men who undergo long-term androgen deprivation therapy (ADT) may experience systemic side effects similar to the classical metabolic syndrome. Exercise is a potential strategy for offsetting the adverse effects of ADT among patients with prostate cancer, resulting in improved muscular resistance and positive outcomes on body size and composition. Fitness (aerobic capacity), fatigue and certain quality of life (QOL) outcomes may also improve in response to a regular exercise regimen. Caution and cardiovascular screening are merited given the elderly population with this disease.

Entities:  

Year:  2014        PMID: 25243044      PMCID: PMC4145703          DOI: 10.5489/cuaj.2315

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  21 in total

1.  Insulin sensitivity during combined androgen blockade for prostate cancer.

Authors:  Matthew R Smith; Hang Lee; David M Nathan
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

Review 2.  Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association.

Authors:  Miriam E Nelson; W Jack Rejeski; Steven N Blair; Pamela W Duncan; James O Judge; Abby C King; Carol A Macera; Carmen Castaneda-Sceppa
Journal:  Med Sci Sports Exerc       Date:  2007-08       Impact factor: 5.411

3.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 5.  Metabolic sequelae associated with androgen deprivation therapy for prostate cancer.

Authors:  Jason E Faris; Matthew R Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

6.  Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

Authors:  Glenn N Levine; Anthony V D'Amico; Peter Berger; Peter E Clark; Robert H Eckel; Nancy L Keating; Richard V Milani; Arthur I Sagalowsky; Matthew R Smith; Neil Zakai
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

7.  Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.

Authors:  Roanne J Segal; Robert D Reid; Kerry S Courneya; Shawn C Malone; Matthew B Parliament; Chris G Scott; Peter M Venner; H Arthur Quinney; Lee W Jones; Monika E Slovinec D'Angelo; George A Wells
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

8.  Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Authors:  Henry K Tsai; Anthony V D'Amico; Natalia Sadetsky; Ming-Hui Chen; Peter R Carroll
Journal:  J Natl Cancer Inst       Date:  2007-10-09       Impact factor: 13.506

Review 9.  Exercise and bone mass in adults.

Authors:  Amelia Guadalupe-Grau; Teresa Fuentes; Borja Guerra; Jose A L Calbet
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Andrew A Renshaw; Marian Loffredo; Philip W Kantoff
Journal:  JAMA       Date:  2008-01-23       Impact factor: 56.272

View more
  1 in total

1.  Effects of a six-month supervised physical exercise program on physical and cardio-metabolic profile and quality of life in patients with prostate cancer on androgen deprivation therapy: a pilot and feasibility study.

Authors:  Natalia S Zabegalina; Michaël M E L Henderickx; Veerle Lamotte; Bart Segers; Gaetane Stassijns; Stefan De Wachter; Lucien Hoekx
Journal:  Cent European J Urol       Date:  2018-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.